EuBiologics Co Ltd
KOSDAQ:206650
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
EuBiologics Co Ltd
Revenue
EuBiologics Co Ltd
Revenue Peer Comparison
068270
302440
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
E
|
EuBiologics Co Ltd
KOSDAQ:206650
|
Revenue
₩70.2B
|
CAGR 3-Years
34%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
|
|
Celltrion Inc
KRX:068270
|
Revenue
₩2.3T
|
CAGR 3-Years
6%
|
CAGR 5-Years
19%
|
CAGR 10-Years
26%
|
|
|
SK Bioscience Co Ltd
KRX:302440
|
Revenue
₩369.5B
|
CAGR 3-Years
18%
|
CAGR 5-Years
30%
|
CAGR 10-Years
N/A
|
|
H
|
Hugel Inc
KOSDAQ:145020
|
Revenue
₩329.6B
|
CAGR 3-Years
12%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
|
P
|
PharmaResearch Co Ltd
KOSDAQ:214450
|
Revenue
₩280.3B
|
CAGR 3-Years
32%
|
CAGR 5-Years
32%
|
CAGR 10-Years
N/A
|
|
A
|
Alteogen Inc
KOSDAQ:196170
|
Revenue
₩121.1B
|
CAGR 3-Years
40%
|
CAGR 5-Years
55%
|
CAGR 10-Years
N/A
|
See Also
What is EuBiologics Co Ltd's Revenue?
Revenue
70.2B
KRW
Based on the financial report for Mar 31, 2024, EuBiologics Co Ltd's Revenue amounts to 70.2B KRW.
What is EuBiologics Co Ltd's Revenue growth rate?
Revenue CAGR 5Y
20%
Over the last year, the Revenue growth was 19%. The average annual Revenue growth rates for EuBiologics Co Ltd have been 34% over the past three years , 20% over the past five years .
You don't have any saved screeners yet
